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Abstract
Mechanical strain provides an anti-adipogenic, pro-osteogenic stimulus to mesenchymal stem cells
(MSC) through generating intracellular signals and via cytoskeletal restructuring. Recently,
mTORC2 has been shown to be a novel mechanical target critical for the anti-adipogenic signal
leading to preservation of β-catenin. As mechanical activation of mTORC2 requires focal
adhesions (FAs), we asked whether proximal signaling involved Src and FAK, which are early
responders to integrin-FA engagement. Application of mechanical strain to marrow-derived MSCs
was unable to activate mTORC2 when Src family kinases were inhibited. Fyn, but not Src, was
specifically required for mechanical activation of mTORC2 and was recruited to FAs after strain.
Activation of mTORC2 was further diminished following FAK inhibition, and as FAK
phosphorylation (Tyr-397) required Fyn activity, provided evidence of Fyn/FAK cooperativity.
Inhibition of Fyn also prevented mechanical activation of RhoA as well as mechanically induced
actin stress fiber formation. We thus asked whether RhoA activation by strain was dependent on
mTORC2 downstream of Fyn. Inhibition of mTORC2 or its downstream substrate, Akt, both
prevented mechanical RhoA activation, indicating that Fyn/FAK affects cytoskeletal structure via
mTORC2. We then sought to ascertain whether this Fyn-initiated signal pathway modulated MSC
lineage decisions. siRNA knockdown of Fyn, but not Src, led to rapid attainment of adipogenic
phenotype with significant increases in adipocyte protein 2, peroxisome proliferator-activated
receptor gamma, adiponectin, and perilipin. As such, Fyn expression in mdMSCs contributes to
basal cytoskeletal architecture and, when associated with FAs, functions as a proximal mechanical
effector for environmental signals that influence MSC lineage allocation.
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Introduction
The mesenchymal stem cell (MSC) pool within bone marrow serves as a critical repository
for lineages that support bone remodeling throughout life. Along with chemical and
hormonal influences on MSC fate, mechanical signals provide significant regulatory control
of MSC lineage allocation. Both static [1,2] and dynamic [3] mechanical cues modulate
MSC differentiation in vitro, both through increasing cytoskeletal architecture [4,5] and by
activation of β-catenin, which protects multipotentiality of the stem cell [6], preventing
adipogenesis [7], and allowing entry into the osteogenic lineage [8]. Force activation of
mTORC2 is a required proximal event for β-catenin activation [9]. Mechanical activation of
pathways affecting MSC lineage allocation is initiated at focal adhesions (FAs) [5], where
cellular tension is generated through the interface of the external microenvironment with the
actin cytoskeleton, via integrin attachments [10,11].
mTORC2 is a multiprotein complex composed of subunits including mTOR, mSin1, GβL,
and rictor. Association of rictor within the mTOR complex defines mTORC2, whereas
mTORC1 contains raptor. The rictor versus raptor association defines mTOR substrate
specificity. Mechanical activation of mTORC2 induces phosphorylation of Akt at Ser-473;
in contrast, mTORC1 is not involved [9]. Akt phosphorylation is an essential event in
mechanical repression of adipogenesis, acting through inhibition of GSK3β via Ser-9
phosphorylation to enhance availability of β-catenin. Furthermore, mTORC2 has been
implicated in cytoskeletal organization [12] and cells deficient in the mTORC2-specific
protein rictor display altered morphology with impaired migration [13]. As mechanical
loading induces changes in the actin cytoskeleton through activation of RhoA, a GTPase
fundamentally associated with actin cytoskeletal dynamics [4,14], we considered the
possibility that mTORC2 might regulate cytoskeletal dynamics through effects on RhoA.
Growth factor signaling, distinct from mechanical activation, can also induce mTORC2
activity: insulin potently induces Akt Ser-473 phosphorylation through activation of
mTORC2. Our previous studies demonstrated that while mechanical inhibition of GSK3β
was prevented in the absence of mTORC2 activity, GSK3β inhibition via insulin did not
require Akt Ser-473 phosphorylation [9]; this suggests that the requirement for mTORC2 in
transmitting mechanical information is unique. The upstream signaling events regulating
mechanical activation of mTORC2/Akt remain unclear.
Mechanical strain activates multiple kinases within the FA complex at the plasma membrane
including extracellular regulated kinase 1/2 (ERK1/2), focal adhesion kinase (FAK), and Src
family kinases (SFKs). Activation of SFKs and FAK are early events following integrin–
extracellular matrix engagement [15]. During cell migration, where cytoskeletal
reorganization propels the cell forward, SFKs transiently translocate to newly formed FAs
[16]. New FAs are also generated in response to mechanical strain along with the
development of radial actin stress fibers [5], suggesting SFKs might be involved in
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mechanical cytoskeletal restructuring, paralleling their involvement in integrin-induced
RhoA activation [17]. Cell adhesion and spreading, events that initiate FA formation, require
both SFKs and FAK for full activation and recruitment of paxillin to the FA complex [18].
FAK functions cooperatively with SFKs during mechanical signaling, and cyclical strain
increases the Src-FAK association [19]. Both FAK and SFKs are involved in actin
cytoskeleton dynamics in response to mechanical force [20,21]. We hypothesized that
mTORC2 regulates cytoskeletal rearrangement in response to mechanical strain through
FAK and SFKs.
In this work, we used marrow-derived MSCs (mdMSCs) to identify a role for the SFK
member Fyn in mechanical activation of mTORC2/Akt. We showed that the SFK isoform
Fyn is necessary for mechanical mTORC2 activation. Strain activation of mTORC2 also
requires FAK, which cooperates with Fyn for maximal activation. Furthermore, we
demonstrate that Fyn and mTORC2 are crucial for mechanical activation of RhoA, and that
mTORC2’s effect is conferred through Akt. This critical signaling pathway not only
decreases mdMSC entrance into adipocyte lineage through enhancing β-catenin signaling as




Fetal bovine serum (FBS) was obtained from Atlanta Biologicals (Atlanta, GA,
www.atlantabio.com). Culture media, trypsin-EDTA, antibiotics, and phalloidin-Alexa488
were from Invitrogen (Carlsbad, CA, www.invitrogen.com). Insulin, dexamethasone,
indomethacin, rapamycin, Akti1/2, KU63794, PF573228, and PP2 were purchased from
Sigma Aldrich (St. Louis, MO, www.sigmaaldrich.com). SU6656 and U0126 inhibitors
were obtained from Calbiochem (La Jolla, CA, www.emdmillipore.com).
RNA-Mediated Interference
mdMSCs were transfected with gene-specific small interfering RNA (siRNA) or control
siRNA (20 nM) using PepMute Plus transfection reagent (SignaGen Labs, Rockville, MD,
www.signagen.com). Medium was replaced at 18 hours with Iscove’s Modified Dulbecco’s
Medium (IMDM) containing FBS (10%, v/v) and penicillin/streptomycin (100 μg/ml).
Mechanical strain was applied 72 hours after initial transfection; adipogenic media was
added 18 hours after transfection. The following Stealth Select siRNAs (Invitrogen) were
used in this study: negative control for rictor 5′-GCCCUCGUUGACUGAAA
GAAUCUGA-3′; rictor 5′-UCAUCUUUCUGACUAAGCGAAG GGC-3′; negative control
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The following antibodies were purchased from Cell Signaling (Danvers, MA,
www.cellsignal.com): Akt (#4685), pAkt Ser-473 (#4058L), rictor (#D16H9), Src (#2110),
pSrc Tyr-418 (#2101), Yes (#3201), and perilipin (#9349). Antibodies against FAK
(sc-558), pFAK Tyr-397 (sc-11765-R), and RhoA (sc-418) were purchased from Santa Cruz
Biotechnology (Dallas, TX, www.scbt.com). Anti-Fyn antibody (610163) was from BD
Biosciences (San Jose, CA, www.bdbiosciences.com). The vinculin antibody (ab91459) was
obtained from Abcam (Cambridge, MA, www.Abcam.com). Antibody recognizing
adipocyte protein 2 (aP2) (XG6174) was purchased from ProSci, Inc. (Poway, CA,
www.prosci-inc.com). The anti-adiponectin antibody (PA1-054) was from Affinity
BioReagents (Rockford, IL, www.pierce-antibodies.com).
Cells and Culture Conditions
mdMSCs [7] were maintained in IMDM with FBS (10%, v/v) and penicillin/streptomycin
(100 μg/ml). For experiments, cells were plated at a density of 6,000–10,000 cells per square
centimeter on collagen-I coated silicone membrane plates (Flexcell International,
Hillsborough, NC, www.flexcellint.com) and cultured for 2–4 days before beginning
experiments. Cells were serum starved overnight in α-Minimal Essential Medium lacking
serum before all assays. Adipogenic medium included dexamethasone (0.1 μM), insulin (5
μg/ml), and indomethacin (50 μM). Pharmacological inhibitors were added 1 hour before
strain experiments at the following concentrations: rapamycin (30 nM), SU6656 (2.5 μM),
PP2 (10 μM), U0126 (10 μM), PF573228 (3 μM), Akti1/2 (40 μM), and KU0063794 (2 μM).
Murine embryonic fibroblasts (MEFs) lacking the Src kinases members Src, Yes, and Fyn
(SYF) and wild-type MEFs were cultured in Dulbecco’s modified Eagle’s medium
(Invitrogen) supplemented with FBS (10%, v/v) and penicillin/streptomycin (100 μg/ml).
SYF cells harboring stably transfected constructs, expressing Src or Fyn, were grown under
the same conditions and were generated as described previously [17].
Mechanical Strain
Uniform biaxial strain was applied to mdMSCs plated on six-well Bioflex Collagen-I coated
plates using the Flexcell FX-4000 system (Flexcell International). A regimen of 2% strain
was delivered at 10 cycles per minute for a total of 100 cycles (10 minutes) for all
experiments. Cells used for phosphorylation induction and RhoA activity assays were lysed
directly following the 100 cycles of strain, whereas cells stained for actin cytoskeleton were
allowed to rest for 3 hours following 100 cycles of strain to enable actin stress fiber
formation.
Western Blotting
Whole cell lysates were prepared using radio immunoprecipitation assay lysis buffer (150
mM NaCl, 50 mM Tris HCl, 1 mM EGTA, 0.24% sodium deoxycholate, 1% Igepal, pH 7.5)
containing NaF (25 mM) and Na3VO4 (2 mM). Aprotinin, leupeptin, pepstatin, and
phenylmethylsulfonylfluoride (PMSF) were added before each lysis. Whole cell lysates (20
μg) were separated on polyacrylamide gels (7, 9 or 12%) and transferred to polyvinylidene
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difluoride membranes. Membranes were blocked with milk (5%, w/v) diluted in Tris-
buffered saline containing Tween20 (TBS-T, 0.05%). Blots then were incubated overnight at
4°C with the appropriate primary antibodies, washed and incubated with horseradish
peroxidase-conjugated secondary antibody (1:5,000 dilution; Cell Signaling) at room
temperature (RT) for 1 hour. Chemiluminescence was detected with ECL plus (Amersham
Biosciences, Piscataway, NJ, www.gelifesciences.com) and developed. Images were
acquired with a Hewlett Packard Scanjet scanner, and densitometry was determined using
NIH ImageJ software version 1.45s.
RhoA Assay
Purification of recombinant proteins and construction of the pGEX4T-1 prokaryotic
expression constructs containing the Rho-binding domain (RBD) of Rhotekin has been
described [22]. Briefly, expression of the fusion proteins in Escherichia coli was induced
using isopropyl β-D-1-thiogalactopyranoside (100 μM) for 12–16 hours at RT. Bacterial
cells were lysed in lysis buffer containing Tris HCl (50 mM, pH 7.6), NaCl (150 mM),
MgCl2 (5 mM), dithiothreitol (1 mM), aprotinin (10 μg/ml), leupeptin (10 μg/ml), and
PMSF (1 mM). Recombinant proteins were purified by incubation with glutathione-
sepharose 4B beads (GE Healthcare, Piscataway, NJ, www.GEHealthcare.com) at 4°C. Pull
down of active RhoA, using glutathione-S-transferase-RBD (GST-RBD) beads, was
performed as described [23]. mdMSC cells were lysed in buffer containing Tris HCl (50
mM, pH 7.6), NaCl (500 mM), Triton X-100 (1%, v/v), SDS (0.1%, v/v), sodium
deoxycholate (0.5%, w/v), MgCl2 (10 mM), orthovanadate (200 μM), and protease
inhibitors. Lysates were clarified by centrifugation, equalized for total volume and protein
concentration and rotated at 4°C for 30 minutes with 50 μg of purified GST-RBD bound to
glutathione-sepharose beads. The bead pellets were washed in lysis buffer three times,
followed by pelleting of the beads by centrifugation between each wash, and subsequently
processed by SDS-polyacrylamide gel electrophoresis.
Immunofluorescence
Following strain and/or treatment with pharmacological inhibitors, cells were fixed with
paraformaldehyde (4%, v/v) for 20 minutes, permeabilized with Triton X-100 (0.1%, v/v)
for 5 minutes at RT, and donkey serum (5%, v/v) blocking buffer diluted in TBS was added
for 30 minutes to block nonspecific epitopes. Cells were washed three times for 10 minutes
each with TBS. The silicone culture membranes were detached from the BioFlex plates
using a scalpel and transferred to wells of six-well plates. Cells were incubated with
phalloidin-conjugated Alexa Fluor-488 (Invitrogen) diluted in TBS (1:100) 30 minutes at
RT. Cells were washed three times for 10 minutes each and the silicone membranes were set
on glass slides, covered, and sealed with mounting medium containing dapi (Invitrogen).
Images were taken using a Zeiss LSM 710 confocal laser scanning microscope running ZEN
2011 software (Carl Zeiss Microscopy, Inc., Thornwood, NY, www.microscopy.zeiss.com),
excitation 488 nm line of the argon ion laser, emission 493–630 nm, objective lens 20× 0.95
Plan Apo.
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Statistical variance was expressed as the means ± SE. Statistical significance was evaluated
using a natural log transformation of the data to make the distribution more symmetric,
followed by analysis using either a t-test or a one-way ANOVA, allowing for unequal
variance (Prism GraphPad, LA Jolla, CA, www.graphpad.com). All experiments were
replicated at least twice to assure reproducibility. Densitometry data, where given, were
compiled from at least three separate biological replicates.
Results
Src-like Kinases Are Critical for Mechanical, but Not Insulin, Activation of Akt
We demonstrated previously that Akt was critical to mechanical inhibition of GSK3β and
that mechanical activation of Akt was mTORC2 dependent [9]. Here, we confirmed that Akt
Ser-473 phosphorylation was increased following 100 cycles of biaxial strain (Fig. 1A, 1B)
and that strain-induced phosphorylation of Akt Ser-473 was disrupted by pharmacological
inhibition of mTOR activity (KU0063794) (Fig. 1A). Our previous study showed that
inhibition of mTORC1 activity, using rapamycin, failed to block mechanical Akt Ser-473
phosphorylation [9]. To confirm that mechanical activation of Akt Ser-473 was mTORC2-
specific, and independent of mTORC1, the mTORC2-associated subunit rictor was knocked
down using siRNA, and compared with cultures treated with a control siRNA. Rictor-
deficient mdMSCs demonstrated dramatically reduced Akt Ser-473 phosphorylation after
strain compared with cells treated with control siRNA (Fig. 1B). To determine whether Src-
like kinases were necessary for strain activation of mTORC2, mdMSCs were treated with
the SFK inhibitor PP2 (10 μM). Mechanical phosphorylation of Akt was suppressed in the
presence of PP2 compared with vehicle treated controls (Fig. 1C). We confirmed the role of
SFKs in mechanical phosphorylation of Akt by treating mdMSCs with the SFK inhibitor
SU6656 (2.5 μM) before strain application. While strain significantly (p < .05) increased
pAkt Ser-473, inhibiting SFK activity prevented Akt Ser-473 phosphorylation by strain.
Densitometry demonstrated the significant increase in pAkt Ser-473 in strained compared
with nonstrained cells and the inhibition of Akt phosphorylation following treatment with
SU6656 (Fig. 1D). In contrast to treatment with SFK inhibitors, the ERK1/2 inhibitor U0126
(10 μM) did not prevent strain-induced phosphorylation of Akt Ser-473; this was verified by
densitometry (Fig. 1E).
Furthermore, we asked whether SFKs were necessary for insulin activation of mTORC2.
mTORC2 plays a unique role in Akt Ser-473 phosphorylation in response to insulin
stimulation [24], an effect that appears to be PI3K-dependent, enabling Akt relocation to the
plasma membrane [25]. Insulin treatment of mdMSCs produced a robust increase in pAkt
Ser-473, as expected; however, pretreatment with the SFK inhibitor SU6656 failed to
repress Akt Ser-473 phosphorylation (Fig. 1F). As such, the requirement for SFKs in
phosphorylation of Akt Tyr-473 specifically requires FA contacts that mediate “outside-in”
mechanical signaling, as is distinct from Akt activation by soluble growth factors.
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Fyn Is Required for Mechanical Activation of mTORC2 in mdMSCs
Several SFK isoforms can be activated by mechanical force including Src and Fyn [17]. To
determine the SFK member required for mechanical activation of mTORC2, siRNA was
used to selectively knockdown individual SFK members. Treatment with siRNA against Fyn
reduced Fyn protein to undetectable levels. In the absence of Fyn, strain was not able to
induce phosphorylation of Akt Ser-473 (Fig. 2A). Densitometry analysis demonstrated a
significant increase in pAkt Ser-473 in strained cells compared with nonstrained cells
transfected with a control siRNA, while there was no significant difference in pAkt Ser-473
between strained and non-strained cells following treatment with siRNA against Fyn (Fig.
2A, p < .05). In contrast, knockdown of the Src isoform with siRNA failed to repress
mechanical activation of pAkt Ser-473 (Fig. 2B). As Akt is mTORC2’s effector, in response
to mechanical strain, this data suggests that Fyn’s role is proximal to mTORC2 during
mechanical activation of Akt.
The contribution of the SFK member Yes to mechanical activation of mTORC2 was also
evaluated. Knockdown of Yes did not alter mechanical phosphorylation of Akt Ser-473 in
mdMSCs (Fig. 2C). Further analysis demonstrated that mdMSCs expressed little or none of
the Yes isoforms; MCF7 human breast adenocarcinoma cell lysates were used as a positive
control for Yes expression (Fig. 2C).
MEFs lacking the SFK members SYF were used to further test the requirement for SFKs in
the mechanical activation of Akt. Control MEF cells demonstrated increased Akt
phosphorylation at Ser-473 following 100 cycles of mechanical strain. MEFs lacking SYF
displayed no increase in pAkt Ser-473 following mechanical strain, confirming that SFKs
participate in mechanical activation of Akt (Fig. 2D). Stable transfection of the Src isoform
into SYF cells rescued mechanical phosphorylation of Akt Ser-473, while overexpression of
Fyn failed to enhance Akt Ser-473 phosphorylation in response to strain (Fig. 2D). This
suggests that participation of SFK isoforms in mechanical Akt signaling is cell specific and
that mechanical activation of Fyn is distinct from Src in MSCs.
Fyn and FAK Cooperate in Mechanical mTORC2 Activation
Following mechanical strain or cell attachment, FAK is recruited to integrin/FA sites where
FAK is autophosphorylated on Tyr-397 [26]. FAK activation creates a high affinity binding
site for Src kinases [26,27] enabling SFKs to phosphorylate FAK, resulting in full activation
of both kinases. The cooperative activity between Src kinases and FAK led us to ask
whether FAK might contribute to mechanical activation of mTORC2. We found that
pharmacological inhibition of FAK (PF573228, 3 μM) prevented mechanical activation of
mTORC2, as determined by Akt Ser-473 phosphorylation (Fig. 3A). Mechanical strain
induced a significant (p < .05) increase in FAK Tyr-397 phosphorylation, which did not
occur in mdMSCs pretreated with the SFK inhibitor SU6656 (2.5 μM) (Fig. 3B).
SFK phosphorylation at Tyr-418 is known to occur during integrin ligation [28] and
following force activation [17,29]; surprisingly, in mdMSCs mechanical strain did not
induce phosphorylation at this site following strain durations of 2–30 minutes (10 cycles per
minute) (Fig. 3C, showing 100 cycles of strain). Fyn is located within FA complexes [30]
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and association of Fyn with FAs, at sites of integrin attachment, is known to cooperate in
SFK activation [26]. To determine whether mechanical strain directed Fyn localization, we
evaluated its association with FAs by immunoprecipitating the FA-associated protein
vinculin. Mechanical strain induced a significant (p < .05) association between Fyn and
vinculin when compared with nonstrained control samples (Fig. 2E), suggesting that
mechanical strain promotes Fyn recruitment to sites of focal contacts. The absence of Fyn
phosphorylation at Tyr-418 suggests an alternate mechanism of Fyn activation, perhaps
dependent on the relocalization of Fyn to adhesion sites.
Mechanical RhoA Activity in mdMSCs Is Fyn Dependent
Src kinases play an important role in cytoskeletal rearrangement by regulating RhoA activity
[31]. Fyn contributes to the mechanical activation of RhoA by regulating the exchange of
GDP/GTP via the guanine exchange factor LARG [17]. We demonstrated previously that
mechanical strain activates RhoA in mdMSCs [5]. Here, we examined whether SFKs were
necessary for strain-dependent RhoA activation. When compared with nonstrained control
cells (Fig. 4A), strained cells developed numerous actin stress fibers spanning the cell (Fig.
4B). Inhibition of SFK activity prevented actin stress fiber formation (Fig. 4D) compared
with unstrained (static) control cells (Fig. 4C).
Having shown that actin stress fiber reorganization was dependent on SFKs, we next
investigated the influence of SFKs on strain-dependent activation of RhoA using
pharmacological inhibition of SFKs and siRNA knockdown. Cyclical strain enhanced RhoA
activity as expected [5]. Importantly, the strain-dependent RhoA activation was abrogated
when cells were treated with the SFK pharmacological inhibitor SU6656 (Fig. 4E). As Fyn
was identified as the SFK isoform necessary for mechanical activation of mTORC2 (Fig.
2A), we tested its requirement for mechanical activation of RhoA in mdMSCs. Indeed,
mechanical activation of RhoA was prevented following knockdown of Fyn with siRNA
(Fig. 4F). These data indicate that actin stress fiber formation in response to mechanical
strain is dependent on Fyn activation of RhoA.
mTORC2/Akt Is Required for Mechanical Activation of RhoA
The absence of the mTORC2 binding partner rictor results in abnormal cell morphology [13]
and mTORC2 has been implicated in cytoskeletal reorganization [12]. Mechanical strain
generates actin stress fiber struts, which span the cell and enhance rigidity and cellular
structure, an adaptation that influences MSC lineage commitment [5]. We hypothesized that
mTORC2 was a critical step in mechanical regulation of RhoA. To test this, active RhoA
was pulled down from total cell lysates following mechanical strain. RhoA activity was
significantly (p < .05) increased comparing strained to unstrained mdMSCs, while addition
of the mTOR inhibitor KU0063794 prevented mechanical activation of RhoA (Fig. 5A). A
previous study reported that treatment with rapamycin, which acutely inhibits mTORC1,
suppressed RhoA activity [32], implicating mTOR complex 1 in the regulation of RhoA
activation. Treatment of MSCs with rapamycin for 1 hour failed to suppress mechanical
activation of RhoA (Fig. 5C). In contrast, siRNA-mediated knockdown of the mTORC2-
specific subunit rictor prevented RhoA activation following mechanical strain (Fig. 5D).
These data indicate that mTOR complex 2, but not complex 1, is involved in mechanical
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activation of RhoA in mdMSCs. As Akt is a target of mTORC2 activation (Fig. 1B) [9], we
investigated if Akt served as an intermediary for mTORC2 activation of RhoA. Treatment
with the pharmacological Akt inhibitor Akti1/2 prevented mechanical activation of RhoA
(Fig. 5B). These data suggest that Akt is the mTORC2 substrate necessary for strain-induced
RhoA activation.
Fyn Restrains Adipogenic Lineage Commitment of mdMSCs
The requirement for Fyn participation in mechanical mTORC2/Akt activation in MSCs is
not shared by MEFs (Fig. 2D), suggesting that Fyn might have a unique role in
determination of MSC lineage. Indeed, several studies have implicated SFKs in adipogenic
lineage commitment. A previous study demonstrated that inhibition of SFK activity
decreased adipogenesis in MEF cells, but it was the Src, rather than the Fyn isoform that
was involved [33]. Furthermore, Fyn knockout mice displayed decreased whole-body
adipose tissue [34]. In contrast to this suggested proadipogenic stimulus of Fyn, here we
demonstrate that Fyn activation restrains adipogenic commitment of mdMSCs. Following
knockdown of Fyn using siRNA, we found a significant increase in the adipogenic markers
aP2 (p < .05), peroxisome proliferator-activated receptor gamma (PPARγ) (p < .05),
adiponectin (APN) (p < .05), and perilipin (p < .01) when cells were cultured in adipogenic
conditions for four days (Fig. 6A). Protein quantities for adipogenic markers were
normalized to β-actin expression and fold increases (over treatment with a control siRNA)
were 2.1 ± 0.3, 6.3 ± 0.9, 35.4 ± 3.4, and 89.9 ± 11.3 for aP2, PPARγ, APN, and perilipin,
respectively (Fig. 6B). In contrast to the enhanced adipogenic commitment of mdMSCs
following knockdown of Fyn, siRNA treatment of Src resulted in no observable differences
in aP2, PPARγ, or perilipin by Western blot, while expression of APN was increased in the
absence of Src (Fig. 6C). These data demonstrate that Fyn is a critical regulator of
adipogenic lineage commitment decisions in MSCs from the marrow of murine long bones,
where Fyn serves to restrain adipocyte formation.
Discussion
The lineage fate of mdMSCs has a critical influence on the health and maintenance of bone,
where bone density is inversely proportionate to adipogenic commitment of these progenitor
cells [8,35]. Lineage decisions are dependent on cell architecture, where the structure of the
cytoskeleton influences how cells respond to the local physical environment [2]. We have
shown here that mechanical activation of a specific SFK isoform, Fyn, cooperating with
FAK, is required for a signaling pathway that, through mTORC2/Akt, controls MSC
cytoskeletal architecture by activating RhoA. This indicates that Fyn/FAK signaling
participates in MSC sensing of its physical environment, and reinforces signaling events that
are important for lineage selection. Fyn/FAK activation is a crucial proximate step in
mechanical mTORC2 activation, and is distinct from mTORC2 activation by growth factors.
As such, Fyn is a critical early activator of mechanical signals emanating from FAs that
define cytoskeletal structure and lineage decisions.
Src kinases are recruited to FAs following strain or cell adhesion where they cooperate with
FAK, inducing reciprocal activations. Here, we show that FAK is also necessary for
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mechanical activation of Akt. The cooperative activation of FAK and SFKs is initiated upon
autophosphorylation of FAK Tyr-397, creating a high affinity binding site for SFKs [26].
Cyclical strain increases the Src-FAK association in osteoblasts [19] and SFK involvement
in strain-induced FAK phosphorylation is consistent with previous work showing that
inhibition of SFKs prevented FAK Tyr-397 phosphorylation [36].
Strain and fluid shear stress have been shown to induce Src Tyr-418 phosphorylation in
intestinal epithelial cells [36] and MC3T3-E1 preosteoblastic cells [29]. Here, we did not
detect phosphorylation of Fyn or Src at Tyr-418 in mdMSCs following mechanical strain,
but we did show that Fyn was newly recruited to FAs where FAK is localized. This suggests
that Fyn-dependent activation of mTORC2, rather than requiring phosphorylation of
Tyr-418, involves a strain-dependent recruitment of Fyn to the FA complex where it comes
into association and interacts with FAK.
Both FAK and SFKs participate in the regulation of actin cytoskeleton reorganization in
response to mechanical force [20,21]. In mdMSCs, we now show that strain-induced actin
stress fiber formation is blocked when SFKs are inhibited with SU6656. Inhibition of SFKs
and knockdown of Fyn prevented mechanical activation of RhoA, an essential regulator of
actin stress fiber formation. While Fyn has been shown to be partially responsible for
integrin-induced LARG activation [17], we believe that Fyn’s major target is the mTORC2
kinase, which precedes Akt activation of RhoA. We showed that the mTORC2 complex
requires Fyn to sense mechanical strain and to transmit that signal to RhoA. Indeed,
mTORC2 has been implicated in basal cytoskeletal organization [37] as rictor-deficient cells
display altered morphology with impaired migration [13]. It is known that rictor,
independently mTORC2, influences the organization of the actin cytoskeleton by
suppressing RhoGDI2 expression, a negative regulator of Rho GTPases [13]. As well, in
mdMSCs, mechanical activation of RhoA was dependent on mTOR complex two but not
complex 1, consistent with previous work from our lab that rapamycin treatment (mTORC1-
specific) did not suppress strain-induced Akt Tyr-473 phosphorylation [9]. These results
suggest that while mechanical activation of RhoA via mTORC2 is a generalizable
phenomenon, that the proximal signal, Fyn/FAK in the case of mdMSCs, may provide cell
specificity.
While mechanical strain of mdMSCs consistently produced a rise in RhoA activity, we also
found an unexpected rise in basal RhoA activation following treatment with mTOR or Akt
inhibitors. A similar basal enhancement of RhoA activity was seen when SFKs were
inhibited or Fyn expression was knocked down. This effect was not observed following
treatment with rapamycin (specific for mTORC1). A previous study also demonstrated high
constitutive activation of RhoA following knockdown of the mTORC2-specific binding
partner rictor [38], suggesting that the Fyn/mTORC2/Akt pathway might supply a tonic
inhibitory control over basal RhoA activity. RhoA activity is modulated by a variety of
regulatory molecules such as guanine nucleotide dissociation inhibitors (GDIs) [39], guanine
exchange factors (GEFs), and GTPase activating proteins (GAPs) [40]. Rho GDIs function
to sequester RhoA in the cytosol, limiting its ability to be fully activated. It is possible that
the absence of mTORC2 signaling reduces GDI sequestration of RhoA in the cytosol,
making RhoA readily available for GEF-mediated activation. Alternatively, suppression of
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mTORC2/Akt activity might directly activate Rho GAPs, leading to decreased RhoA
activity.
Mechanical regulation of MSC differentiation has a direct effect on cell lineage, as both
static [1,2] and dynamic [3] mechanical cues modulate lineage commitment in vitro, in part
through stiffening of the cell cytoskeleton [4]. These direct effects on the cytoskeleton of
uncommitted marrow MSCs likely contribute to the increased osteogenesis that occurs
during exercise-induced skeletal loading [41], while reduced loading results in increases in
marrow adipocytes [42,43]. RhoA, which directly modulates the cytoskeleton, also affects
lineage selection, as inhibition of RhoA suppresses osteogenesis and enhances adipogenesis
[44]. Our findings add detail to the cytoskeletal control of MSC lineage selection. We found
that Fyn knockdown led to a dramatic enhancement of mdMSC adipogenic lineage
commitment. Additionally, knockdown of Src had little effect on adipogenesis: expression
of aP2, PPARγ, and Perilipin were not altered following Src knockdown. Interestingly, APN
expression was specifically increased with Src deficiency, suggesting a direct effect not
related to promotion of adipogenic phenotype. The involvement of Fyn, but not Src, in
adipogenesis of mdMSCs was indeed consistent with our data showing that Fyn, but not Src,
was required for mechanical activation of mTORC2. As Fyn altered cytoskeletal assembly
in response to mechanical strain, and was required for RhoA activation, it is likely that Fyn
modulates mdMSC lineage through its effects on cytoskeletal structure.
Src family kinases may have tissue and activator-specific roles in controlling cell
differentiation. In mdMSCs, knock down of Src had little influence on adipogenesis in
comparison with the robust increase in fat formation when Fyn was deficient. In contrast to
our findings, Fyn depleted 3T3-L1 preadipocytes and Fyn null MEFs displayed suppressed
adipocyte formation [34]. Adding further complexity, mice with global Fyn knock-out had
reduced adipose mass and adipocyte size [34] but showed increased subcutaneous adipose
formation [45], highlighting the variable effects of Fyn in different fat depots. Finally,
deleting all SFK isoforms from MEFs decreased their adipogenic potential, yet re-
expression of the Src isoform in these cells rescued adipogenesis [33]. This may indicate
that the contribution of a specific SFK iso-form to lineage selection is not only dependent on
the incoming stimulus (e.g., physical vs. soluble), but also on responses specific to the cell
type (e.g., mdMSC vs. MEF).
This study provides in vitro evidence of the role of Fyn in mechanical activation of an anti-
adipogenic pathway and demonstrates the ability of this SFK isoform to inhibit adipogenesis
in mesenchymal progenitors from the bone marrow compartment. These findings should
provide the basis for further in vivo studies, with the goal of identifying physiologically
relevant loading regimens or pharmacological targets that can restrain adipose formation
within the bone marrow cavity. Activating these anti-adipogenic pathways should lead to
enhanced skeletal integrity by increasing the available pool of osteogenic progenitors.
Summary
In summary, the cytoskeletal structure of mdMSCs is influenced by, and responsive to, its
mechanical environment, and contributes to the promulgation of signaling events that
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influence lineage commitment. FA assembly and stress fiber formation provide a more rigid
cellular framework that restrains adipogenesis and promotes osteogenic differentiation. We
have identified the Src family kinase Fyn, cooperating with FAK, as a novel proximate
participant in mechanical activation of mTORC2. mTORC2, via its downstream substrate
Akt, induced mechanical activation of RhoA. RhoA ensures that the cytoskeleton adapts to
mechanical signals. In conclusion, mechanical strain utilizes Fyn as a critical regulator of
mTORC2/Akt/RhoA signaling to influence lineage commitment decisions of mdMSCs.
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Mechanical activation of mTORC2 requires Src kinases. (A): Mechanical treatment of
marrow-derived mesenchymal stem cells (mdMSCs; 2% strain, 100 cycles) induces Akt
Ser-473 phosphorylation. Pharmacological inhibition of mTOR (KU0063794, 2 μM)
prevented strain-induced Akt phosphorylation. (B): Strain-induced phosphorylation of Akt
Ser-473 was not observed after knockdown of the mTORC2 component rictor with siRNA.
(C): Inhibition of SFKs (PP2, 10 μM) prevented strain activation of Akt Ser-473. (D): The
SFK inhibitor SU6656 (2.5 μM) blocked mechanical Akt Ser-473 phosphorylation.
Densitometry shows that pAkt Ser-473 was significantly reduced (n = 3, p < .05). (E):
Blocking ERK1/2 activity (U0126, 10 μM) did not suppress the mechanical activation of
Akt. Densitometry showed a significant increase in Akt phosphorylation following strain in
the absence or presence of the ERK1/2 inhibitor (n = 3, p < .05). (F): Akt Ser-473
phosphorylation after insulin stimulation was significantly increased (p < .0001) and was not
prevented by SFK inhibition (SU6656, 2.5 μM). Significance was confirmed by
densitometry analysis. Abbreviation: DMSO, dimethyl sulfoxide.
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Mechanical activation of mTORC2 requires Fyn. (A): Mechanical strain (2%, 100 cycles) of
marrow-derived mesenchymal stem cells (mdMSCs) significantly increased Akt Ser-473
phosphorylation. Knockdown of Fyn with siRNA blocked mechanical phosphorylation of
Akt. Densitometry confirms significance levels (n = 3, p < .05). (B): Mechanical activation
of Akt Ser-473 was equivalently enhanced in mdMSCs following with either control siRNA
or siRNA knockdown of Src. Densitometry demonstrates significance (n = 3, p < .05). (C):
Transfection of siRNA targeting the Yes isoform did not reduce mechanical phosphorylation
of Akt Ser-473 in mdMSCs. Compared with MCF7 human breast adenocarcinoma cell
lysates, mdMSCs expressed little to none of the Yes isoform. (D): Mechanical strain (2%,
100 cycles) of MEFs increased Akt Ser-473 phosphorylation. pAkt Ser-473 was not
enhanced following strain in MEFs lacking the SFKs Src, Yes, and Fyn (SYF). Re-
expression of Src (+Src) rescued the mechanical activation of Akt Ser-473, whereas Akt
phosphorylation remained suppressed with re-expression of Fyn (+Fyn). Abbreviations:
mdMSC, marrow-derived mesenchymal stem cell; MEF, murine embryonic fibroblast; SYF,
Src, Yes, and Fyn.
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Force activation of mTORC2 requires cooperative activation of Fyn and focal adhesion
kinase (FAK). (A): Strain significantly increased Akt Ser-473 phosphorylation following
strain. Treatment with the FAK inhibitor PF573228 (3 μM) blocked force-induced Akt
phosphorylation. Densitometry confirms significance (n = 3, p < .05). (B): FAK Tyr-397
phosphorylation was significantly increased after 100 cycles of strain (2%). Inhibition of Src
kinases (SU6656, 2.5 μM) significantly reduced FAK phosphorylation as shown in
densitometry measurements (n-3, p < .05). (C): Compared with nonstrained controls,
Src/Fyn phosphorylation at Tyr-418 was not significantly increased, densitometry n = 3.
(D): The FA protein vinculin was immunoprecipitated from marrow-derived mesenchymal
stem cell lysates and Western blotting was used to detect Fyn pulled down in the precipitate.
There was significantly increased association of Fyn with the FA protein vinculin following
mechanical strain, as shown by densitometry (n = 3, p < .05). Abbreviation: DMSO,
dimethyl sulfoxide.
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Mechanical formation of actin stress fibers requires Fyn activation of RhoA. (A–D):
Marrow-derived mesenchymal stem cells (mdMSCs) were stained with Alexa488-
conjugated Phalloidin and dapi following strain (2%, 100 cycles) (B, D) or under
nonstrained conditions (A, C). Images were captured using a 20× 0.95 plan apo lens. Cells
were treated with either DMSO as a vehicle control (A, B) or with the Src inhibitor SU6656
(2.5 μM) (C, D). (E): mdMSCs were treated with Src kinase inhibitor (SU6656, 2.5 μM) or
vehicle control and ± strain. Active RhoA (RhoA-GTP) was pulled down from cell lysates
and compared with total RhoA by Western blot. (F): Fyn expression was knocked down in
mdMSCs using siRNA or treatment with a control siRNA sequence. Following strain
application active RhoA was pulled down and analyzed by Western blot. Abbreviation:
DMSO, dimethyl sulfoxide.
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Fyn regulates RhoA activity through mTORC2/Akt. (A): RhoA activity was analyzed by
pulling down active RhoA following inhibition of mTOR (KU0063794, 2 μM).
Densitometry shows a significant increase in RhoA activation following strain and when
marrow-derived mesenchymal stem cells (mdMSCs) were treated with the mTOR inhibitor
under nonstrained conditions (n = 3, p < .05). (B): Active RhoA was pulled down following
inhibition of Akt (AKTi1/2, 40 μM) and ± strain. Densitometry demonstrated a significant
increase in active RhoA following strain (n = 3, p < .05), which was blocked with addition
of the Akt inhibitor. (C): RhoA activity was determined following inhibition of mTORC1
with rapamycin (30 nM) and ± strain. (D): The mTORC2 binding partner rictor was
knocked down with siRNA and cells were strained or left unstrained. Active RhoA was
pulled down and samples were analyzed by Western blot. Abbreviation: DMSO, dimethyl
sulfoxide.
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Fyn restrains adipogenic commitment in mdMSCs. (A): Fyn expression was knocked down
using siRNA and cells were cultured in adipogenic media for 4 days. Protein expression of
adipocyte protein 2 (aP2), peroxisome proliferator-activated receptor gamma (PPARγ),
adiponectin (APN), and perilipin by Western blot. (B): Densitometry measurements of three
separate experiments showed a significant increase in expression of each adipogenic marker
when treatment with Fyn siRNA was compared with control siRNA (*p < .05, **p < .01).
Protein expression was normalized to β-actin. (C): Src was knocked down using siRNA and
cells were cultured in adipogenic media for 4 days. Expression of adipogenic markers was
determined by Western blotting. Abbreviations: aP2, adipocyte protein 2; APN, adiponectin;
PPARγ, peroxisome proliferator-activated receptor gamma.
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